期刊文献+

盐酸雷莫司琼的异构体杂质检测及异构体化影响因素

Determination of (S)-Enantiomer of Ramosetron Hydrochloride by HPLC and Influencing Factors of the Enantiomeric Conversion
原文传递
导出
摘要 建立了高效液相色谱法检测盐酸雷莫司琼及其对映异构体,并考察了高温、光照、强酸、强碱等影响因素对异构体杂质含量的影响,从而为该药物的制剂、工艺研究和贮藏条件选择提供参考。采用YMC Chiral NEA(R)色谱柱,以50 mmol/L磷酸二氢钠缓冲液(pH 5.2):乙腈(50:50)为流动相,检测波长306 nm。盐酸雷莫司琼对映异构体间的分离度大于1.5;(S)-型异构体杂质在0.04~1.00μg/ml范围内线性关系良好,定量限为0.032μg/ml,平均回收率为100.2%(RSD=0.32%)。影响因素考察结果表明,在强碱条件下,盐酸雷莫司琼会发生向(S)-型异构体转化,提示制剂处方工艺研究中须避免碱性因素的影响。本方法准确、稳定,可为本品的质量控制提供参考。 An HPLC method was established for the chiral separation and determination of ramosetron hydrochloride and its (S)-enantiomer. The effects of temperature, humidity, light, acid, alkali and oxidant on the enantiomeric conversion from (R)-configuration to (S)-configuration in ramosetron hydrochloride active pharmaceutical ingredients (API) were also investigated. A YMC chiral NEA(R) column was used, with the mobile phase of 50 mmol/L sodium dihydrogen phosphate buffer solution(pH 5.2):acetonitrile(50:50), at the detection wavelength of 306 nm. The resolution of the enantiomers was more than 1.5. It was linear for (S)-ramosetron hydrochloride in the range of 0.04-1.00 μg/ml, with LOQ of 0.032 μg/ml. Its average recovery was 100.2%, with RSD of 0.32%. The results of stability test revealed that ramosetron hydrochloride would undergo an enantiomeric conversion from (R)-configuration to (S)-configuration in alkaline environment, which suggested that alkalinity should be avoided during its preparation and formulation process. The established method was accurate and stable, which provided a quality control method for ramosetron hydrochloride.
作者 沈晨 夏旭 高文彦 曾珊珊 叶金翠 SHEN Chen;XIA Xu;GAO Wenyan;ZENG Shanshan;YE Jincui(Zhejiang Academy of Medical Science Hangzhou 310000)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2018年第8期1155-1160,共6页 Chinese Journal of Pharmaceuticals
基金 浙江省科技厅项目(2014F10034 2016F50016和2017C33147) 浙江省卫生高层次创新人才培养工程项目
关键词 盐酸雷莫司琼 对映体分离 高效液相色谱 ramosetron hydrochloride chiral separation HPLC
  • 相关文献

参考文献5

二级参考文献23

  • 1朱全刚,胡晋红,曾华武.皮肤羧酸酯酶代谢的立体选择性[J].药学学报,2005,40(4):322-326. 被引量:11
  • 2谢沐风.如何建立高效液相色谱法测定有关物质的方法[J].中国医药工业杂志,2007,38(1):45-48. 被引量:62
  • 3国家药典委员会.《中国药典》.2005年版.二部[S].化学工业出版社,2005:附录Ⅺ ⅩF. 被引量:1
  • 4Sloan KB, Wasdo S. Designing for topical delivery:prodrugs can make the difference [ J ]. Med Res Rev,2003,23 (6) :763 - 793. 被引量:1
  • 5Redinbo MR, Bencharit S, Potter PM. Human carboxylesterase 1: from drug metabolism to drug discovery [J]. Biochem Soc Trans, 2003,31(3):620-624. 被引量:1
  • 6Afouna MI, Fincher TK, Khan MA, et al. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective [ J ]. Chirality, 2003, 15(5) :456 -465. 被引量:1
  • 7Humerickhouse R, Lohrbach K, Li L, et al.Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2 [J]. Cancer Res, 2000,60(5) :1189 - 1192. 被引量:1
  • 8ZengLG GongSX XiaZN.HPLC determination of dexketoprofen [J].药物分析杂志,2002,22(1):74-74. 被引量:1
  • 9JinDY LiMF.分克隆实验指南 [M]: 2nd Ed[M].Beijing:Science Press,1993.304-366. 被引量:1
  • 10Friedberg T. Molecular biological methods for characterizing drug-metabolizing enzymes in hepatic and extrahepatic tissues [ J ]. Skin Pharmcol Appl Physiol,1998,11(1) :61-69. 被引量:1

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部